Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1956 2
1969 1
1971 2
1973 1
1974 1
1976 2
1977 1
1978 2
1979 3
1980 1
1982 3
1983 4
1984 5
1985 5
1987 1
1988 8
1989 6
1990 3
1991 3
1992 6
1993 12
1994 4
1995 3
1996 5
1997 2
1998 5
1999 6
2000 6
2001 14
2002 15
2003 15
2004 19
2005 16
2006 16
2007 21
2008 18
2009 22
2010 25
2011 28
2012 35
2013 28
2014 21
2015 39
2016 35
2017 31
2018 34
2019 32
2020 33
2021 44
2022 26
Text availability
Article attribute
Article type
Publication date

Search Results

587 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.
Maguire AM, Bennett J, Aleman EM, Leroy BP, Aleman TS. Maguire AM, et al. Among authors: leroy bp. Mol Ther. 2021 Feb 3;29(2):442-463. doi: 10.1016/j.ymthe.2020.11.029. Epub 2020 Dec 3. Mol Ther. 2021. PMID: 33278565 Free PMC article. Review.
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S, Cross D, Marshall KA, Walshire J, Kehoe TL, Reichert H, Davis M, Raffini L, George LA, Hudson FP, Dingfield L, Zhu X, Haller JA, Sohn EH, Mahajan VB, Pfeifer W, Weckmann M, Johnson C, Gewaily D, Drack A, Stone E, Wachtel K, Simonelli F, Leroy BP, Wright JF, High KA, Maguire AM. Russell S, et al. Among authors: leroy bp. Lancet. 2017 Aug 26;390(10097):849-860. doi: 10.1016/S0140-6736(17)31868-8. Epub 2017 Jul 14. Lancet. 2017. PMID: 28712537 Free PMC article. Clinical Trial.
Squamous cell carcinoma.
Webb JL, Burns RE, Brown HM, LeRoy BE, Kosarek CE. Webb JL, et al. Among authors: leroy be. Compend Contin Educ Vet. 2009 Mar;31(3):E9. Compend Contin Educ Vet. 2009. PMID: 19412903 Review.
Adult Refsum Disease.
Waterham HR, Wanders RJA, Leroy BP. Waterham HR, et al. Among authors: leroy bp. 2006 Mar 20 [updated 2021 Sep 30]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. 2006 Mar 20 [updated 2021 Sep 30]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. PMID: 20301527 Free Books & Documents. Review.
The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene.
Chung DC, Bertelsen M, Lorenz B, Pennesi ME, Leroy BP, Hamel CP, Pierce E, Sallum J, Larsen M, Stieger K, Preising M, Weleber R, Yang P, Place E, Liu E, Schaefer G, DiStefano-Pappas J, Elci OU, McCague S, Wellman JA, High KA, Reape KZ. Chung DC, et al. Among authors: leroy bp. Am J Ophthalmol. 2019 Mar;199:58-70. doi: 10.1016/j.ajo.2018.09.024. Epub 2018 Sep 28. Am J Ophthalmol. 2019. PMID: 30268864 Free PMC article.
Reply.
Foveau P, Leroy B, Berrod JP, Conart JB. Foveau P, et al. Among authors: leroy b. Am J Ophthalmol. 2018 Nov;195:244-245. doi: 10.1016/j.ajo.2018.07.039. Epub 2018 Sep 1. Am J Ophthalmol. 2018. PMID: 30177217 No abstract available.
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.
Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, Marshall KA, McCague S, Reichert H, Davis M, Simonelli F, Leroy BP, Wright JF, High KA, Bennett J. Maguire AM, et al. Among authors: leroy bp. Ophthalmology. 2019 Sep;126(9):1273-1285. doi: 10.1016/j.ophtha.2019.06.017. Epub 2019 Jun 22. Ophthalmology. 2019. PMID: 31443789 Free article. Clinical Trial.
587 results